In everyday work, we use both the extensive scientific knowledge gained over the years, as well as the latest and most advanced technologies.
The combination of these two elements allows us to achieve the best results, reduce costs and shorten cycle times research.
The scope of
Currently, BioContract manufactures one medicinal product: genetically modified melanoma vaccine AGI-101H. The vaccine is an investigational (designated for clinical trials) medicinal product manufactured in aseptic conditions.
The device is used for controlled freezing of biological materials (temperature range: +40 °C ÷ -180°C)
The device provides controlled, optimal conditions for running cell cultures. In addition, it is equipped with an independent system of continuous monitoring of climate parameters.